Tezspire
Payments companies reported to CMS as associated with Tezspire. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tezspire, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tezspire
These are the largest totals companies reported as associated with Tezspire. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Helberg | Yankton, SD | Pulmonary Disease | $369,337.18 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $273,599.58 |
| Charles Lane | Lynchburg, VA | Allergy & Immunology | $257,619.70 |
| Michael Marcus | Brooklyn, NY | Pediatric Allergy/Immunology | $256,047.06 |
| Maria Mascolo | Rincon, GA | Pulmonary Disease | $187,693.44 |
| David Mares | Anderson, IN | Pulmonary Disease | $172,935.71 |
| Samuel Louie | Sacramento, CA | Pulmonary Disease | $168,700.09 |
| Joseph Diaz | San Antonio, TX | Allergy & Immunology | $168,688.64 |
| Jeffrey Weiss | Riverdale, NJ | Allergy | $164,331.45 |
| Rohit Katial | Denver, CO | Allergy & Immunology | $161,387.45 |
Prescribed Tezspire?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.